Search results
Results from the WOW.Com Content Network
E. W. Kemble's "Death's Laboratory" on the cover of Collier's (June 3, 1905). A patent medicine, also known as a proprietary medicine or a nostrum (from the Latin nostrum remedium, or "our remedy") is a commercial product advertised to consumers as an over-the-counter medicine, generally for a variety of ailments, without regard to its actual effectiveness or the potential for harmful side ...
The issue of novelty often arises during patent examination, because of inadvertent and/or partial disclosures by inventors themselves prior to filing a patent application. [citation needed] Unlike the laws of most countries, the US patent law provides for a one-year grace period in cases of inventor's own prior disclosure. [28]
The Drug Price Competition and Patent Term Restoration Act (Public Law 98-417), informally known as the Hatch-Waxman Act, is a 1984 United States federal law that established the modern system of generic drug regulation in the United States.
In Indonesia, the Patent Office (Direktorat Jenderal Kekayaan Intelektual, "Directorate General of Intellectual Property") is a governmental agency overseeing intellectual property rights (HKI). A public body carrying out this function has existed since Dutch colonial times.
In 1945, it was renamed again as Rumah Sakit Umum Pusat (RSUP). In 1964, after Indonesia's independence, the name changed to Rumah Sakit Tijpto Mangunkusumo (RSTM), now RSCM, to match the Indonesian language. In 1994, the hospital was renamed Rumah Sakit Umum Pusat Dr. Cipto Mangunkusumo (RSUP Dr. Cipto Mangunkusumo). In 2008, a new building ...
The reverse doctrine of equivalents is a legal doctrine of United States patent law, according to which a device that appears to literally infringe a patent claim, by including elements or limitations that correspond to each element or limitation of the patent claim, nonetheless does not infringe the patent, because the accused device operates on a different principle.
Some companies file patent applications primarily to be able to cross license the resulting patents, as opposed to trying to stop a competitor from bringing a product to market. [5] In the early 1990s, for example, Taiwanese original design manufacturers , such as Hon Hai , rapidly increased their patent filings after their US competitors ...
Business method patents are a class of patents which disclose and claim new methods of doing business. This includes new types of e-commerce, insurance, banking and tax compliance etc. Business method patents are a relatively new species of patent and there have been several reviews investigating the appropriateness of patenting business methods.